Welcome to the Measuring Patient Engagement Summit Blog

Click to explore all of our content related to the 2026 event.

Untitled design (1)

A Deep Dive into Pfizer's Rare Disease Engagement Framework

Behind the hemophilia model that exceeded all brand activation goals and influenced senior leadership decision-makingultimately expanding the model - metrics turned advocacy into a strategic priority 

Untitled design

CISCRP's 2025 Perceptions & Insights Study - Trust, Drivers of Participation, & Retention

Explore CISCRP's framework for understanding what matters most to participants at different stages of the trial lifecycle, from awareness and decision-making, to retention, and post-study communication

1

Our Sit-Down with Kyverna Therapeutics' Executive Director of Patient Advocacy

"What I always value most about gatherings like this is the opportunity to learn from others who are tackling the same challenges from different perspectives - patient organizations, industry teams, researchers, and engagement leaders…" 

networking at OEAPs 2026

Genentech & Why Patient Engagement Is So Important Right Now

"Patient engagement has shifted from a nice-to-have corporate social responsibility to core evidence for regulatory and commercial teams" 

Healthcare professionals attending Measuring Patient Engagement Summit Europe conference sessions
Explore the Agenda

Unlock actionable insights from leading patient engagement experts through case studies, interactive workshops, and panels designed to show how to measure and quantify engagement impact.

Sponsor exhibition stand at Measuring Patient Engagement Summit Europe healthcare conference
Partner With Us

Showcase your solutions and connect with top industry stakeholders, becoming a go-to partner for organizations aiming to embed patient voices and demonstrate tangible value.

Speaker presenting at Measuring Patient Engagement Summit Europe healthcare conference
Join Patient Engagement Leaders

Shape the conversation on patient-centric innovation, exchange best practices, and build meaningful connections that drive measurable impact across trials, access, and development.